Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
742.00
+7.00 (0.95%)
At close: May 28, 2025, 3:30 PM KST
Bridge Biotherapeutics Market Cap
Bridge Biotherapeutics has a market cap or net worth of 37.79 billion as of May 28, 2025. Its market cap has decreased by -34.25% in one year.
Market Cap
37.79B
Enterprise Value
23.48B
Revenue
11.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
742.00
Market Cap Chart
Since December 20, 2019, Bridge Biotherapeutics's market cap has decreased from 300.15B to 37.79B, a decrease of -87.41%. That is a compound annual growth rate of -31.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 351.11T |
SK hynix | 139.79T |
Samsung Biologics | 73.02T |
LG Energy Solution | 65.05T |
Hanwha Aerospace | 41.85T |
Hyundai Motor Company | 39.07T |
KB Financial Group | 37.41T |
HD Hyundai Heavy Industries | 36.57T |